Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP
- PMID: 35901834
- DOI: 10.1016/S1470-2045(22)00191-7
Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP
Abstract
Local cervical treatment for squamous intraepithelial lesion (SIL) or cervical intraepithelial neoplasia (CIN) removes or ablates a cone-shaped or dome-shaped part of the cervix that contains abnormal cells. This Series paper introduces the 2022 terminology for cone dimensions after local conservative treatment for SIL, CIN, or early invasive cervical cancer. The terminology was prepared by the Nomenclature Committee of the European Society of Gynaecologic Oncology, the European Federation for Colposcopy, the International Federation of Cervical Pathology and Colposcopy, and the European Society of Pathology. Cone length should be tailored to the type of transformation zone. Treatment of SIL or CIN is associated with an increased risk of preterm birth, which escalates with increasing cone length. There is a lack of agreement regarding terms used to report excised specimen dimensions both intraoperatively and in the pathology laboratory. Consensus is needed to make studies addressing effectiveness and safety of SIL or CIN treatment comparable, and to facilitate their use to improve accuracy of antenatal surveillance and management. This Series paper summarises the current terminology through a review of existing literature, describes new terminology as agreed by a group of experts from international societies in the field of cervical cancer prevention and treatment, and recommends use of the new terminology that will facilitate communication between clinicians and foster more specific treatment guidelines that balance obstetrical harm against therapeutic effectiveness.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Similar articles
-
Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.BJOG. 2017 Feb;124(3):495-502. doi: 10.1111/1471-0528.14247. Epub 2016 Aug 9. BJOG. 2017. PMID: 27506510
-
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia.J Low Genit Tract Dis. 2023 Apr 1;27(2):131-145. doi: 10.1097/LGT.0000000000000732. J Low Genit Tract Dis. 2023. PMID: 36951985 Free PMC article.
-
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.Int J Gynecol Cancer. 2023 Apr 3;33(4):446-461. doi: 10.1136/ijgc-2022-004213. Int J Gynecol Cancer. 2023. PMID: 36958755 Free PMC article. Review.
-
Value of the International Federation for Cervical Pathology and Colposcopy (IFCPC) Terminology in predicting cervical disease.J Low Genit Tract Dis. 2007 Jul;11(3):158-65. doi: 10.1097/01.lgt.0000265778.36797.03. J Low Genit Tract Dis. 2007. PMID: 17596761
-
Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement.Lancet Oncol. 2025 Mar;26(3):e140-e151. doi: 10.1016/S1470-2045(24)00524-2. Lancet Oncol. 2025. PMID: 40049205 Review.
Cited by
-
Risk factors related to recurrence after surgical excision procedure for cervical dysplasia.Hippokratia. 2023 Oct-Dec;27(4):132-140. Hippokratia. 2023. PMID: 39372323 Free PMC article.
-
Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-g-Methoxy Poly(Ethylene Glycol)/Combretastatin A4/BLZ945 Nanoparticles for Cervical Cancer Therapy.Int J Nanomedicine. 2023 Nov 22;18:6901-6914. doi: 10.2147/IJN.S441131. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38026524 Free PMC article.
-
Associations Between Preoperative Inflammatory Indices and Residual or Recurrent Cervical Intraepithelial Neoplasia Post Loop Electrosurgical Excision Procedure.J Inflamm Res. 2024 Nov 13;17:8741-8751. doi: 10.2147/JIR.S485698. eCollection 2024. J Inflamm Res. 2024. PMID: 39559397 Free PMC article.
-
A predictive model for residual lesions after LEEP surgery in CIN III patients.Front Med (Lausanne). 2023 Dec 11;10:1326833. doi: 10.3389/fmed.2023.1326833. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38148909 Free PMC article.
-
Rate of Involved Endocervical Margins According to High-Risk Human Papillomavirus Subtype and Transformation Zone Type in Specimens with Cone Length ≤ 10 mm versus > 10 mm-A Retrospective Analysis.Life (Basel). 2023 Aug 20;13(8):1775. doi: 10.3390/life13081775. Life (Basel). 2023. PMID: 37629632 Free PMC article.